Abstract: The present invention relates to 5-azido levulinic acid, a process for its preparation, its use. Using 5-azido levulinic acid as starting material for the synthesis of 5-amino levulinic acid hydrochloride it is possible to obtain the latter in good yield an in pharmaceutical acceptable quality. 5-Azido levuliniv acid is synthesized in that methyl 5-bromo levulinate and/or methyl 5-chloro levulinate is converted with aqueous hydrochloric acid and as a result of an incomplete bromine/chlorine exchange at the C-5-postion a mixture of 5-chloro levulinic acid and 5-bromo levulinic acid is obtained, and the obtained 5-chloro levulinic acid, a mixture of 5-chloro levulinic acid and 5-bromo levulinic acid and the pure 5-bromo levulinic acid is transferred into 5-azido levulinic acid by conversion with a nucleophilic azide.
Abstract: It is an object of the present invention to provide a process for producing aliphatic carboxylic acid, which can stabilize operation of a distillation column upon production of aliphatic carboxylic acid by reducing a water content in an aqueous aliphatic carboxylic acid solution by a distillation column, and can shorten a time during the non-steady state such as at starting up of distillation column operation.
Abstract: Catalysts such as antimony halides, which are useful in fluorination reactions involving hydrogen fluoride, may be reduced during the reaction and require regeneration. Regenerative oxidation is usually carried out by introducing elemental halogen, preferably fluorine or chlorine, into the reaction mixture. In accordance with the invention elemental halogen is prevented from coming into contact with starting materials or intermediate products which are reactive therewith. This is preferably achieved by withdrawing part of the reaction mixture from the reactor, mixing the withdrawn part with chlorine or fluorine in order to regenerate the catalyst, and thereafter returning the withdrawn part to the reactor.
Abstract: A method of decomposing a Michael addition reaction product formed as a by-product in the production step of a(meth)acrylic ester and recovering (meth)acrylic acid, a (meth)acrylic ester and an alcohol, in which the formation of an olefin as a by-product can be suppressed. A method of thermally decomposing a by-product at the time of production of a (meth)acrylic ester using an alcohol bearing a branched chain and having 3 or more carbon atoms, wherein the decomposition reaction is carried out in the absence of a catalyst.
Abstract: The present invention relates to a method for producing (meth)acrylic acid comprising a process of recovering (meth)acrylic acid as an aqueous (meth)acrylic acid from a (meth) acrylic acid-containing gas mixture produced by the catalytic gas phase oxidation of at least one reactant selected from the group consisting of propane, propylene, isobutylene and (meth) acrolein, and a system usable for the method.
Type:
Grant
Filed:
February 18, 2005
Date of Patent:
January 15, 2008
Assignee:
LG Chem, Ltd.
Inventors:
Seong Pil Kang, Seok Hwan Choi, Kyoung Su Ha, Geon Yong Kim, Boo Gon Woo, Sang Youn Lee, Young Bae Kim, Koo Hyun Kang
Abstract: The present invention is to provide a stabilized aqueous aminopolycarboxylate solution composition and a method of stabilizing the aminopolycarboxylate through preventing the same from caking. An aqueous aminopolycarboxylate solution composition containing an aminopolycarboxylate represented by the following general formula (1): in the formula, X may be the same or different and represents a hydrogen atom, an alkali metal atom, or an ammonium group, which has a D-form/L-form molar ratio of an aspartic acid skeleton of the aminopolycarboxylate of 1/0 to 0.7/0.3 or 0.3/0.7 to 0/1, has a solid concentration of 25 to 60 mass %, and has a pH value of not more than 11.
Abstract: The invention relates to novel synthesis methods for the preparation of the intermediates, which are suitable for the preparation of statin derivatives, especially to novel synthesis methods of the intermediate of formula VI wherein Ra? and Rc? are each independently of the other hydrogen or a hydroxy-protecting group or together are a bridging hydroxy-protecting group, and Rb is a carboxy-protecting group, which methods are carried out by conversion of the intermediate of formula XVI wherein Ra? and Rc? are each independently of the other hydrogen or a hydroxy-protecting group, R* and R** are each independently of the other hydrogen or an amide-protecting group, and Rb is a carboxy-protecting group; which methods proceed to further new intermediates and methods for their preparation
Type:
Grant
Filed:
July 2, 2002
Date of Patent:
January 8, 2008
Assignee:
Teva Pharmaceutical Industries, Ltd
Inventors:
Reinhold Öhrlein, Gabriele Baisch, Hans Jörg Kirner, Stephan Burkhardt, Martin Studer, Frank Bienewald
Abstract: The invention relates to a method of producing fatty acid monoesters and polyhydroxylic alcohols by means of transesterification between a polyhydroxylic alcohol and a compound that is selected from a fat of animal origin, a fat of vegetable origin, and a fatty acid methyl ester. The invention is characterised in that the transesterification reaction is performed in the presence of basic solid catalysts, said basic solids being oxides that are selected from mixed oxides of one or more monovalent metals and one or more trivalent metals, mixed oxides of one or more divalent metals and one or more trivalent metals, and mixtures of same.
Type:
Grant
Filed:
April 12, 2006
Date of Patent:
December 25, 2007
Assignees:
Consejo Superior de Investigaciones Cientificas, Universidad Politecnica de Valencia, Universiti Malaya
Inventors:
Avelino Corma Canòs, Sara Iborra Chornet, Alexandra Isabelle Velty, Sharifah Bee Abd Hamid
Abstract: One aspect of the present invention relates to methods for synthesizing milnacipran or congeners thereof. Another aspect of the present invention relates to asymmetric methods for synthesizing enantiomerically enriched milnacipran or congeners thereof. The present invention also relates to methods for synthesizing intermediates useful in the non-asymmetric or asymmetric methods for synthesizing enantiomerically enriched milnacipran or congeners thereof.
Type:
Grant
Filed:
April 1, 2005
Date of Patent:
December 18, 2007
Assignee:
Collegium Pharmaceutical, Inc.
Inventors:
Stephen L. Buchwald, Timothy M. Swager, Roman V. Rariy
Abstract: Crude acrylic acid is purified batchwise by crystallization by a process which comprises at least one purification stage and at least one stripping stage and in which at least the first stripping stage is carried out in a different crystallizer from the first purification stage.
Type:
Grant
Filed:
May 16, 2001
Date of Patent:
December 11, 2007
Assignee:
BASF Aktiengesellschaft
Inventors:
Bernd Eck, Dieter Baumann, Joerg Heilek, Klaus Joachim Mueller-Engel
Abstract: An allyl-containing compound represented by following Formula (3): wherein R2, R3, R4, R5 and R6 may be the same as or different from one another and each represent hydrogen atom or an organic group; R7 represents an organic group; and Y represents oxygen atom or sulfur atom, is produced by reacting an allyl ester compound represented by following Formula (1): wherein R1 represents hydrogen atom or an organic group; and R2, R3, R4, R5 and R6 are as defined above, with a compound represented by following Formula (2): R7—Y—H??(2) wherein R7 is an organic group; and Y is as defined above, in the presence of at least one transition element compound.
Abstract: The present invention relates to a fluorination method for the synthesis of halofluoroorganic compounds which can be used, inter alia, as precursors in the synthesis of 2,3-unsaturated fluoroorganic carbonyl compounds comprising a fluorine substituent in the 2 position.
Type:
Grant
Filed:
August 6, 2001
Date of Patent:
December 4, 2007
Assignee:
Solvay (Societe Anonyme)
Inventors:
Véronique Mathieu, Francine Janssens, James Franklin
Abstract: A compound represented by the following formula (1), a pharmaceutically acceptable salt thereof or an optically active form thereof: wherein each symbol is as defined in the specification. A compound having a calcium-sensing receptor antagonistic action, a pharmaceutical composition comprising the compound, particularly a calcium receptor antagonist and a therapeutic drug for osteoporosis are provided.
Abstract: The invention relates to radically copolymerizable acetophenone or benzophenone derivatives, which may be obtained by reacting a) acrylic or methacrylic compounds, which contain at least one isocyanate-reactive group [compounds a)], with b) compounds, which contain at least two isocyanate groups [compounds b)] and c) acetophenone or benzophenone derivatives, which contain at least one isocyanate-reactive group [compounds c)]. Said invention also relates to copolymers, which contain said copolymerizable photoinitiators, as well as to the use of said copolymers in UV-crosslinkable substances, in particular hot-melt pressure-sensitive adhesives.
Type:
Grant
Filed:
October 4, 2002
Date of Patent:
December 4, 2007
Assignee:
BASF Aktiengesellschaft
Inventors:
Wolf-Dieter Balzer, Ulrich Erhardt, Volker Ladenberger, Harald Meyer, Bernd Bruchmann, Karl-Heinz Schumacher
Abstract: Described is a method for improving the spreading properties of fatty alcohol containing cosmetic ingredients by providing a fatty alcohol containing starting material and adding an effective amount of acylating source [e.g., R1C)?O)OC(?O)R2, where R1 is an alkyl substituent of the acyl group having between 1 and 5 carbons; where R2 is a long chain fatty alkyl subsistent (non-limiting examples are unsaturated substituents such as CH3—(CH2)7—CH?CH—CH2—(CH2)x—, and saturated substituents such as CH3—(CH2)y—, wherein x ranges from 4 to 12, and y ranges from 14 to 22, and the like)], wherein the spreading properties of the starting material are increased over the spreading properties originally exhibited.
Type:
Grant
Filed:
October 10, 2003
Date of Patent:
December 4, 2007
Assignee:
International Flora Technologies, Ltd.
Inventors:
Robert Kleiman, Sambasivarao Koritala, John C. Hill
Abstract: The present invention provides a process for producing compounds useful as raw materials for various fluororesins in high yields in few steps from inexpensive and readily available starting materials. The following compound (1) and the following compound (2) are reacted to form the following compound (3), then the compound (3) is fluorinated in a liquid phase to form the following compound (4), and the ester bonds in the compound (4) are dissociated to form the compound (5), or the compound (5) and the compound (6). HOCH2-Q-O—(CH2)3—OH,??(1) CRBCOX,??(2) RBCOOCH2-Q-O—(CH2)3—OCORB,??(3) RBFCOOCF2-QF-O—(CF2)3—OCORBF,??(4) FCO-QF-O—(CF2)2—COF,??(5) RBFCOF.
Abstract: The present invention relates to optically active boronate derivatives which are useful as intermediates for the synthesis of HMG-CoA enzyme inhibitors such as atorvastatin, cerivastatin rosuvastatin, pitavastatin, and fluvastatin.
Type:
Grant
Filed:
February 25, 2002
Date of Patent:
November 27, 2007
Assignee:
Biocon Limited
Inventors:
Tom Thomas Puthiaparampil, Sumithra Srinath, Madhavan Sridharan, Sambasivam Ganesh
Abstract: An unsaturated, cyclic orthoester is prepared by reacting an unsaturated carboxylic acid with glycidol, thereby obtaining a reaction mixture; and adding an orthoester to the reaction mixture, thereby obtaining said unsaturated, cyclic orthoester.
Type:
Grant
Filed:
April 21, 2006
Date of Patent:
November 20, 2007
Assignee:
Degussa AG
Inventors:
Johannes Ruwwe, Jutta Hessing, Kerstin Bodmann
Abstract: The invention concerns a method for preparing polyisocyanates by cyclodimerization of isocyanate functions borne by initial monomer isocyanates. The invention is characterised in that it comprises steps which consist in: a) providing a reaction medium comprising initial monomer isocyanates, optionally in the presence of a solvent; b) adding to said reaction mixture a (cyclo)dimerization catalyst comprising a compound of the family of super acids; c) heating the reaction medium to a temperature ranging between 0° C. and 300° C., advantageously between 20° C. and 200° C. until the desired rate of transformation is obtained; d) optionally inactivating or eliminating the reaction catalyst; and e) optionally eliminating the unreacted monomer.
Abstract: A method for dehydrogenofluorination for transforming an aromatic carbamoyl fluoride into a corresponding isocyanate, is provided. The method includes subjecting a carbamoyl fluoride to a temperature not less than 80° C. in a solvent wherein the carbamoyl fluoride is in a dissolved or finely dispersed state in the solvent. The method is applicable to organic synthesis.